Texas health officials say no link has been found between a compounded drug and the death of two patients who developed blood infections after receiving it before its recall.
The results of a long-term major federal study that was done in Texas is easing worries about the safety of a hormone-blocking drug that can lower a man’s chances of developing prostate cancer.
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.
An Alzheimer’s treatment from Eli Lilly and Co. failed to slow memory decline in two separate patient studies, but the drug did show some potential to help in mild cases of the mind-robbing condition that is notoriously difficult to treat.
A drug “take-back” program in Tarrant County has netted a huge stash of old medications. Organizations across Tarrant County have had three take-back events since 2010 and another is slated for later this month.